Can A New Vitiligo Registry Move The Needle For Thermo Fisher (TMO)?
Thermo Fisher Scientific (NYSE:TMO) mostly sells the instruments and supplies that let other companies do science, not the treatments themselves.
Thermo Fisher Scientific Inc. (TMO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 2,915,715 | $1,461,823,432 | +3% | 0.44% |
| 2. | Unisphere Establishment Hani Lazkani (Ceo) | 2,060,000 | $1,032,801,600 | 8.79% | |
| 3. | Viking Global Andreas Halvorsen | 1,937,415 | $971,342,384 | +17% | 2.77% |
| 4. | Farallon Capital Thomas Steyer | 1,049,185 | $526,019,392 | +20% | 2.43% |
| 5. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,007,394 | $505,067,056 | +59% | 0.22% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $535.93 | 4 | $2,143.73 | 14,268 | 2024-12-09 | Filing | |
| $555.89 | 16 | $8,894.24 | 14,264 | 2024-11-07 | Filing | |
| $526.15 | 4 | $2,104.60 | 13,101 | 2023-06-26 | Filing | |
| $134.16 | 1,000 | $134,160.00 | 14,636 | 2015-12-11 | Filing | |
| $45.84 | 36 | $1,650.24 | 25,914 | 2010-08-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $613.12 | 11,440 | $7,014,092.80 | 14,784 | 2026-08-19 | Filing | |
| $600.00 | 14,300 | $8,580,000.00 | 20,994 | 2026-08-11 | Filing | |
| $600.00 | 11,200 | $6,720,000.00 | 20,994 | 2026-08-11 | Filing | |
| $584.81 | 420 | $245,620.20 | 2,966 | 2026-08-07 | Filing | |
| $593.31 | 117 | $69,417.27 | 0 | 2026-08-07 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 30,919,632 | $15,501,866,869 | 0.23% | |
| 2. | 24,276,316 | $12,171,173,789 | 0.26% | |
| 3. | 16,825,879 | $8,443,627,719 | 0.25% | |
| 4. | 14,084,488 | $7,061,398,716 | 0.31% | |
| 5. | 10,763,066 | $5,396,172,492 | 0.29% |
News See All
Abbott vs. Thermo Fisher: Is Diversification or the Life Sciences Recovery the Better Bet?
Abbott Laboratories (NYSE:ABT) delivered strong fiscal Q2 2026 results, beating quarterly estimates and raising its annual profit forecast as robust demand for its cancer diagnostics and medical devices...
Thermo Fisher (TMO) vs Danaher (DHR): Which Life Sciences Stock Looks Better Positioned?
Thermo Fisher Scientific Inc.
Analysts Appear Bullish on Thermo Fisher (TMO): Is The Stock Really a Buy After Earnings?
Thermo Fisher Scientific Inc.
Thermo Fisher (TMO) Climbs 8.7% on Solid Earnings, Price Target Upgrades
Thermo Fisher Scientific Inc.
What Makes Thermo Fisher Scientific (TMO) an Attractive Long-Term Bet?
Dodge & Cox Fund, an investment management company, released its second-quarter 2026 investor letter for “Dodge and Cox Stock Fund”. A copy of the letter can be downloaded here.
Billionaire Steven Cohen’s Top 11 Dividend Stock Picks
Reuters reported in April that Cohen is making changes to the firm's leadership by passing the title of president to Co-Chief Investment Officer Harry Schwefel.
Is Thermo Fisher Scientific Inc. (TMO) a Top Life Sciences Tools Stock After New Analyst Coverage?
TheFly reported on June 1 that Wolfe Research analyst Mike Polark initiated coverage of TMO with an Outperform rating and set a $535 price target.
10 Best Weight Loss Drug Stocks to Buy in 2026
The anti-obesity drug (AOM) market in the United States is rapidly changing structurally.
14 Best S&P 500 Stocks to Buy Now According to Analysts
As of the writing of this piece, the S&P 500 index has surged by 8.35% since the beginning of 2026.
Hedge Fund Resource Center